Journey Medical (DERM) FCF Margin (2020 - 2026)
Journey Medical's (DERM) quarterly FCF Margin came in at 18.27% in Q1 2026, up 3983.0% YoY from 0.45% in Q1 2025, and up 146.75% on a QoQ basis from 39.08% in Q4 2025.
Journey Medical (DERM) FCF Margin (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of FCF Margin data on file, last reported at 18.27% in Q1 2026.
- Quarterly FCF Margin rose 3983.0% year-over-year to 18.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.46% (up 210.0% YoY) and the FY2025 annual result came in at 20.11%, up 2365.0% from the prior year.
- FCF Margin advanced to 18.27% in Q1 2026, from 39.08% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 54.28% in Q3 2023 to a low of 108.28% in Q4 2023.
- A 5-year average of 22.65% and a median of 21.55% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin sank 10462 bps — and 2024, when it surged 12591 bps.
- Tracing DERM's FCF Margin over 5 years: stood at 24.09% in 2022, then plunged by 349 bps to 108.28% in 2023, then surged by 116 bps to 17.63% in 2024, then slumped by 322 bps to 39.08% in 2025, then surged by 147 bps to 18.27% in 2026.
- The last three FCF Margin figures came in at 18.27% (Q1 2026), 39.08% (Q4 2025), and 14.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Journey Medical | 205.79 Mn | 180.15 Mn | 12.37 Mn | -9.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.37% |
| Mar 31, 2026 | 18.27% |
| Dec 31, 2025 | -39.08% |
| Sep 30, 2025 | -14.00% |
| Jun 30, 2025 | -6.28% |
| Mar 31, 2025 | -21.55% |
| Dec 31, 2024 | 17.63% |
| Sep 30, 2024 | -7.91% |
| Jun 30, 2024 | -34.84% |
| Mar 31, 2024 | -38.52% |
| Dec 31, 2023 | -108.28% |
| Sep 30, 2023 | 54.28% |
| Jun 30, 2023 | 23.40% |
| Mar 31, 2023 | -48.96% |
| Dec 31, 2022 | -24.09% |
| Sep 30, 2022 | -45.18% |
| Jun 30, 2022 | -18.04% |
| Mar 31, 2022 | -91.92% |
| Dec 31, 2021 | -18.30% |
| Sep 30, 2021 | 36.22% |